IE32432B1 - Formulations for introducing alkoxybenzamide into the systematic circulatory system - Google Patents
Formulations for introducing alkoxybenzamide into the systematic circulatory systemInfo
- Publication number
- IE32432B1 IE32432B1 IE206/68A IE20668A IE32432B1 IE 32432 B1 IE32432 B1 IE 32432B1 IE 206/68 A IE206/68 A IE 206/68A IE 20668 A IE20668 A IE 20668A IE 32432 B1 IE32432 B1 IE 32432B1
- Authority
- IE
- Ireland
- Prior art keywords
- alkoxybenzamide
- circulatory system
- ortho
- feb
- hcl
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 238000009472 formulation Methods 0.000 title 1
- 230000009897 systematic effect Effects 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 abstract 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 abstract 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 abstract 1
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- MKXZASYAUGDDCJ-SZMVWBNQSA-N LSM-2525 Chemical compound C1CCC[C@H]2[C@@]3([H])N(C)CC[C@]21C1=CC(OC)=CC=C1C3 MKXZASYAUGDDCJ-SZMVWBNQSA-N 0.000 abstract 1
- NPPQSCRMBWNHMW-UHFFFAOYSA-N Meprobamate Chemical compound NC(=O)OCC(C)(CCC)COC(N)=O NPPQSCRMBWNHMW-UHFFFAOYSA-N 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- JPKKQJKQTPNWTR-KQAYXBCTSA-N [(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2r)-3-hydroxy-2-phenylpropanoate;sulfuric acid;hydrate Chemical compound O.OS(O)(=O)=O.C1([C@H](CO)C(=O)OC2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1.C1([C@H](CO)C(=O)OC2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 JPKKQJKQTPNWTR-KQAYXBCTSA-N 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 229960004782 chlordiazepoxide Drugs 0.000 abstract 1
- ANTSCNMPPGJYLG-UHFFFAOYSA-N chlordiazepoxide Chemical compound O=N=1CC(NC)=NC2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 ANTSCNMPPGJYLG-UHFFFAOYSA-N 0.000 abstract 1
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 abstract 1
- 229960003291 chlorphenamine Drugs 0.000 abstract 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 abstract 1
- 229960001985 dextromethorphan Drugs 0.000 abstract 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 abstract 1
- 229960002179 ephedrine Drugs 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000019634 flavors Nutrition 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- 229940039009 isoproterenol Drugs 0.000 abstract 1
- 229960004815 meprobamate Drugs 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 239000006199 nebulizer Substances 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 229960001412 pentobarbital Drugs 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- OCSOHUROTFFTFO-UHFFFAOYSA-N styramate Chemical compound NC(=O)OCC(O)C1=CC=CC=C1 OCSOHUROTFFTFO-UHFFFAOYSA-N 0.000 abstract 1
- 229960001059 styramate Drugs 0.000 abstract 1
- 239000006190 sub-lingual tablet Substances 0.000 abstract 1
- 229940098466 sublingual tablet Drugs 0.000 abstract 1
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nutrition Science (AREA)
- Otolaryngology (AREA)
- Physiology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61705867A | 1967-02-20 | 1967-02-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE32432L IE32432L (en) | 1968-08-20 |
| IE32432B1 true IE32432B1 (en) | 1973-08-08 |
Family
ID=24472090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE206/68A IE32432B1 (en) | 1967-02-20 | 1968-02-19 | Formulations for introducing alkoxybenzamide into the systematic circulatory system |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3560625A (zh) |
| AT (1) | AT277448B (zh) |
| BE (1) | BE711048A (zh) |
| DE (1) | DE1667872A1 (zh) |
| ES (1) | ES349148A1 (zh) |
| FR (1) | FR7355M (zh) |
| GB (1) | GB1209849A (zh) |
| GR (1) | GR36834B (zh) |
| IE (1) | IE32432B1 (zh) |
| NL (1) | NL6802422A (zh) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0037943B1 (en) * | 1980-03-31 | 1985-08-14 | Teijin Limited | Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom |
| DE69230151T2 (de) * | 1992-12-04 | 2000-03-09 | Mayor Pharmaceuticals Laboratories, Inc. | Sprühfähige analgetische zusammensetzung und verfahren zu irher verwendung |
| KR100886668B1 (ko) * | 2001-02-14 | 2009-03-04 | 지더블유 파마 리미티드 | 약학적 제제 |
| US10004684B2 (en) | 2001-02-14 | 2018-06-26 | Gw Pharma Limited | Pharmaceutical formulations |
| GB0103638D0 (en) * | 2001-02-14 | 2001-03-28 | Gw Pharmaceuticals Ltd | Pharmaceutical formulations |
| US6730330B2 (en) | 2001-02-14 | 2004-05-04 | Gw Pharma Limited | Pharmaceutical formulations |
| EP1542657B8 (en) | 2002-08-14 | 2012-03-14 | GW Pharma Limited | Cannabinoid liquid formulations for mucosal amdinistration |
-
1967
- 1967-02-20 US US617058A patent/US3560625A/en not_active Expired - Lifetime
- 1967-11-18 GR GR670136834A patent/GR36834B/el unknown
-
1968
- 1968-01-11 ES ES349148A patent/ES349148A1/es not_active Expired
- 1968-02-07 DE DE19681667872 patent/DE1667872A1/de active Pending
- 1968-02-15 GB GB7524/68A patent/GB1209849A/en not_active Expired
- 1968-02-19 IE IE206/68A patent/IE32432B1/xx unknown
- 1968-02-19 FR FR140313A patent/FR7355M/fr not_active Expired
- 1968-02-19 AT AT152468A patent/AT277448B/de not_active IP Right Cessation
- 1968-02-20 NL NL6802422A patent/NL6802422A/xx unknown
- 1968-02-20 BE BE711048D patent/BE711048A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE1667872A1 (de) | 1971-07-15 |
| NL6802422A (zh) | 1968-08-21 |
| ES349148A1 (es) | 1969-09-01 |
| US3560625A (en) | 1971-02-02 |
| GR36834B (el) | 1969-03-15 |
| IE32432L (en) | 1968-08-20 |
| GB1209849A (en) | 1970-10-21 |
| AT277448B (de) | 1969-12-29 |
| BE711048A (zh) | 1968-07-01 |
| FR7355M (zh) | 1969-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3929985A (en) | Anhydrous candicidin foam compositions | |
| GB2062465B (en) | Topical preparation containing nitroglycerine and optionally other medicaments | |
| GB1405088A (en) | Slow release formulation | |
| IE791172L (en) | Pharmaceutical compositions containing urea | |
| GB2029441A (en) | Powder aerosol composition | |
| JPS51148013A (en) | Stable insulin preparation for nosal administration | |
| KR960016901A (ko) | 플라보노이드의 구강투여용 제약조성물 | |
| IE32432B1 (en) | Formulations for introducing alkoxybenzamide into the systematic circulatory system | |
| HU171226B (hu) | Insekticidnye, akaricidnye i fungicidnye kompozicii, i sposob poluchenija proizvodnykh amidokarbonil-tiobarbiturovojj kisloty i soli primenimykh aktivnymi agentami | |
| JPS52128210A (en) | Preparation of soft capsule for 1alpha-hydroxyvitamind derivatives | |
| KR880002524A (ko) | 니코란딜 외용제 | |
| JPS5350141A (en) | Stabilization of prostaglandin and prostaglandin analogues | |
| IE791995L (en) | Formulation | |
| GB1483840A (en) | Pharmaceutical preparation containing acetylsalicylic aci | |
| JPS5540604A (en) | Improved local topicum | |
| US4083950A (en) | Stable acetylsalicylic acid and phenylpropanolamine salt composition | |
| JPS5781409A (en) | External plaster | |
| JPS53135925A (en) | Decomposition of microbial cells | |
| GB2035801A (en) | Cephradine compositions | |
| JPH0242811B2 (zh) | ||
| JPS5726587A (en) | Stabilization of ascorbic acid oxidase | |
| JPS5668619A (en) | Nifedipine-containing solid composition | |
| JPS54143518A (en) | Method for producing coating composition for solid preparation | |
| JPH05148138A (ja) | アズレンスルホン酸ナトリウムの安定化法および製剤 | |
| CA2622704A1 (en) | Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses |